Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,271 | -76,246 | -57,112 | -36,855 | -17,527 |
| Depreciation Amortization | 391 | 1,301 | 912 | 612 | 313 |
| Accounts payable and accrued liabilities | 4,565 | -3,449 | -3,592 | -2,368 | -3,794 |
| Other Working Capital | 9,952 | -4,635 | -1,444 | 619 | -6,811 |
| Other Operating Activity | -3,892 | 5,515 | 5,042 | 3,348 | 4,289 |
| Operating Cash Flow | $-13,255 | $-77,514 | $-56,194 | $-34,644 | $-23,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -357 | -2,712 | -3,047 | -1,891 | -425 |
| Investing Cash Flow | $-357 | $-2,712 | $-3,047 | $-1,891 | $-425 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64 | 47,804 | 466 | 330 | 211 |
| Financing Cash Flow | $64 | $47,804 | $466 | $330 | $211 |
| Beginning Cash Position | 201,015 | 233,437 | 233,437 | 233,437 | 233,437 |
| End Cash Position | 187,467 | 201,015 | 174,662 | 197,232 | 209,693 |
| Net Cash Flow | $-13,548 | $-32,422 | $-58,775 | $-36,205 | $-23,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,255 | -77,514 | -56,194 | -34,644 | -23,530 |
| Capital Expenditure | -357 | -2,712 | -3,047 | -1,891 | -425 |
| Free Cash Flow | -13,612 | -80,226 | -59,241 | -36,535 | -23,955 |